Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001385386-09-000003
Filing Date
2009-01-06
Accepted
2009-01-06 13:59:27
Documents
1
Effectiveness Date
2009-01-06
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9449
  Complete submission text file 0001385386-09-000003.txt   11015
Mailing Address 8420 W. BYRN MAWR AVENUE SUITE 860 CHICAGO IL 60631
Business Address 8420 W. BYRN MAWR AVENUE SUITE 860 CHICAGO IL 60631 (773) 444-4180
NeuroTherapeutics Pharma, Inc. (Filer) CIK: 0001385386 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: D | Act: 33 | File No.: 021-98351 | Film No.: 09509328